Face to Face Hot Stocks: Restaurant Brands International Inc. (NYSE:QSR), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

stock overview

Restaurant Brands International Inc. (NYSE:QSR)

Restaurant Brands International Inc. (NYSE:QSR) closed at $56.69 on the last trading session with an increase of 0.8%, whereas, it previously closed at $56.24. The company has a market capitalization of $17.18 Billion. The company traded shares of 1.52 Million on the trading day while its three month average volume stands at 1.74 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Restaurant Brands International Inc. (NYSE:QSR) produced diluted EPS of 2.12. The EPS estimate for next year as estimated by analysts is at 2.98 while EPS for next quarter is estimated at 0.56. Earnings per Share growth for this year is reported at 28.6, while the analysts estimated the EPS growth for next year at 2.98% and Earnings growth for next 5 years stands at 19.13% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 40.67%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Restaurant Brands International Inc. (NYSE:QSR) is at 26.8 while the forward p/e is at 19.02. The P/S or Price to Sales ratio of Restaurant Brands International Inc. (NYSE:QSR) stands at 3.3 and Price to Book or P/B for the most recent quarter stands at 7.51. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Restaurant Brands International Inc. (NYSE:QSR) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Restaurant Brands International Inc. (NYSE:QSR) stands at 0, 0 and 0 respectively

The trailing twelve month Revenue of Restaurant Brands International Inc. (NYSE:QSR) is reported at 5.21 Billion with income of 0. The outstanding shares of Restaurant Brands International Inc. (NYSE:QSR) are 303.11 Million. The institutional Ownership of the shares of 81.81 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of Restaurant Brands International Inc. (NYSE:QSR) is ticked at 3.22%, the figure is plummeted -2.48% in the last six months.

Some other important financial aspects to be discussed here for Restaurant Brands International Inc. (NYSE:QSR) is the Mean Target Price estimated by the analysts which stands at 70.5. The 52 week high of Restaurant Brands International Inc. (NYSE:QSR) is placed at 69.86 and 52 week low is standing at 25.08.

Performance wise the shares of Restaurant Brands International Inc. (NYSE:QSR) fell down -4% for the week, it also rise 3.81% for the monthly performance, while for the quarter it went up -1.82%. The shares increase 25.28% for the half year and plummeted for the Year-To-Date performance. The shares of Restaurant Brands International Inc. (NYSE:QSR) shrinked -18.26% for the yearly performance.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) closed at $141.45 on the last trading session with an increase of 0.58%, whereas, it previously closed at $140.64. The company has a market capitalization of $16.24 Billion. The company traded shares of 348972 on the trading day while its three month average volume stands at 472.81 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) produced diluted EPS of -7.57. The EPS estimate for next year as estimated by analysts is at -4.9 while EPS for next quarter is estimated at -1.66. Earnings per Share growth for this year is reported at -7, while the analysts estimated the EPS growth for next year at -4.9% and Earnings growth for next 5 years stands at 46.09% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -10.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands at 47.04 and Price to Book or P/B for the most recent quarter stands at 11.61. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) are reported at 5.4 and 5.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands at -32, -58.4 and -65.4 respectively

The trailing twelve month Revenue of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is reported at 345.2 Million with income of -846200000. The outstanding shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) are 115.97 Million. The institutional Ownership of the shares of 97.5 stands at 0.80%, this figure is decreased -0.02 in the last six months. The insider ownership for the shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is ticked at 0.3%, the figure is plummeted -50.79% in the last six months.

Some other important financial aspects to be discussed here for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is the Mean Target Price estimated by the analysts which stands at 163.78. The 52 week high of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is placed at 167.33 and 52 week low is standing at 83.06.

Performance wise the shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) fell down -3.55% for the week, it also rise 8.04% for the monthly performance, while for the quarter it went up -10.46%. The shares increase 0.96% for the half year and flew up for the Year-To-Date performance. The shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) grew 63.04% for the yearly performance.